PRESERVE 1: A Phase 3 Randomized, Double-blind Trial of Trilaciclib versus Placebo in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Treatment
Locations
Memorial Hospital Central
Memorial Hospital North
Study ID
Protocol Number: 20-6514
More information available at ClinicalTrials.gov: NCT04607668
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers